The described pathogenic mechanisms responsible for the development of C3G, including dense deposit disease (DDD) and C3 GN, are essentially the same as our proposed mechanisms for C3-dominant GI in PSAGN. This evidence concerns the gene C3 and complement 3 glomerulopathy.